1. Home
  2. PVLA vs AMTB Comparison

PVLA vs AMTB Comparison

Compare PVLA & AMTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • AMTB
  • Stock Information
  • Founded
  • PVLA 2015
  • AMTB 1979
  • Country
  • PVLA United States
  • AMTB United States
  • Employees
  • PVLA N/A
  • AMTB N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • AMTB Major Banks
  • Sector
  • PVLA Health Care
  • AMTB Finance
  • Exchange
  • PVLA Nasdaq
  • AMTB Nasdaq
  • Market Cap
  • PVLA 888.0M
  • AMTB 726.3M
  • IPO Year
  • PVLA N/A
  • AMTB N/A
  • Fundamental
  • Price
  • PVLA $81.40
  • AMTB $16.91
  • Analyst Decision
  • PVLA Strong Buy
  • AMTB Buy
  • Analyst Count
  • PVLA 13
  • AMTB 4
  • Target Price
  • PVLA $99.38
  • AMTB $21.75
  • AVG Volume (30 Days)
  • PVLA 163.2K
  • AMTB 375.0K
  • Earning Date
  • PVLA 11-11-2025
  • AMTB 10-28-2025
  • Dividend Yield
  • PVLA N/A
  • AMTB 2.09%
  • EPS Growth
  • PVLA N/A
  • AMTB N/A
  • EPS
  • PVLA N/A
  • AMTB 1.59
  • Revenue
  • PVLA N/A
  • AMTB $388,504,000.00
  • Revenue This Year
  • PVLA N/A
  • AMTB $61.98
  • Revenue Next Year
  • PVLA N/A
  • AMTB $4.00
  • P/E Ratio
  • PVLA N/A
  • AMTB $10.85
  • Revenue Growth
  • PVLA N/A
  • AMTB 51.98
  • 52 Week Low
  • PVLA $11.17
  • AMTB $15.62
  • 52 Week High
  • PVLA $85.30
  • AMTB $26.24
  • Technical
  • Relative Strength Index (RSI)
  • PVLA 59.88
  • AMTB 40.23
  • Support Level
  • PVLA $78.99
  • AMTB $16.70
  • Resistance Level
  • PVLA $85.03
  • AMTB $18.17
  • Average True Range (ATR)
  • PVLA 5.58
  • AMTB 0.54
  • MACD
  • PVLA -0.02
  • AMTB 0.11
  • Stochastic Oscillator
  • PVLA 63.39
  • AMTB 24.39

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About AMTB Amerant Bancorp Inc.

Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.

Share on Social Networks: